Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Epigral: Board Meeting Intimation for Consider And Approval Of Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The ThirdQuarter And Nine Months Ended On 31St December 2025.
News Announcement

Epigral: Board Meeting Intimation for Consider And Approval Of Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The ThirdQuarter And Nine Months Ended On 31St December 2025.

20-Jan-2026 Follow Value Research Online on Google download pdfDownload PDF Epigral

Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the Third Quarter and Nine Months ended on 31st December 2025.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds